Article ; Online: Elevated C-reactive protein increases diagnostic accuracy of algorithm-defined stroke-associated pneumonia in afebrile patients.
International journal of stroke : official journal of the International Stroke Society
2018 Volume 14, Issue 2, Page(s) 167–173
Abstract: Background and aim: Pyrexia-dependent clinical algorithms may under or overdiagnose stroke-associated pneumonia. This study investigates whether inclusion of elevated C-reactive protein as a criterion improves diagnosis.: Methods: The contribution of ...
Abstract | Background and aim: Pyrexia-dependent clinical algorithms may under or overdiagnose stroke-associated pneumonia. This study investigates whether inclusion of elevated C-reactive protein as a criterion improves diagnosis. Methods: The contribution of C-reactive protein ≥30 mg/l as an additional criterion to a Centers for Disease Control and Prevention-based algorithm incorporating pyrexia with chest signs and leukocytosis and/or chest infiltrates to diagnose stroke-associated pneumonia was assessed in 1088 acute stroke patients from 37 UK stroke units. The sensitivity, specificity, and positive predictive value of different approaches were assessed using adjudicated stroke-associated pneumonia as the reference standard. Results: Adding elevated C-reactive protein to all algorithm criteria did not increase diagnostic accuracy compared with the algorithm alone against adjudicated stroke-associated pneumonia (sensitivity 0.74 (95% CI 0.65-0.81) versus 0.72 (95% CI 0.64-0.80), specificity 0.97 (95% CI 0.96-0.98) for both; kappa 0.70 (95% CI 0.63-0.77) for both). In afebrile patients (n = 965), elevated C-reactive protein with chest and laboratory findings had sensitivity of 0.84 (95% CI 0.67-0.93), specificity of 0.99 (95% CI 0.98-1.00), and kappa 0.80 (95% CI 0.70-0.90). The modified algorithm of pyrexia or elevated C-reactive protein and chest signs with infiltrates or leukocytosis had sensitivity of 0.94 (95% CI 0.87-0.97), specificity of 0.96 (95% CI 0.94-0.97), and kappa of 0.88 (95% CI 0.84-0.93) against adjudicated stroke-associated pneumonia. Conclusions: An algorithm consisting of pyrexia or C-reactive protein ≥30 mg/l, positive chest signs, leukocytosis, and/or chest infiltrates has high accuracy and can be used to standardize stroke-associated pneumonia diagnosis in clinical or research settings. Trial registration: http://www.isrctn.com/ISRCTN37118456. |
---|---|
MeSH term(s) | Aged ; Aged, 80 and over ; Algorithms ; C-Reactive Protein/metabolism ; Clinical Decision-Making ; Diagnostic Errors/prevention & control ; Female ; Fever ; Humans ; Male ; Pneumonia/diagnosis ; Pneumonia/epidemiology ; Sensitivity and Specificity ; Stroke/diagnosis ; Stroke/epidemiology ; United Kingdom/epidemiology ; Up-Regulation |
Chemical Substances | C-Reactive Protein (9007-41-4) |
Language | English |
Publishing date | 2018-09-10 |
Publishing country | United States |
Document type | Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2303728-3 |
ISSN | 1747-4949 ; 1747-4930 |
ISSN (online) | 1747-4949 |
ISSN | 1747-4930 |
DOI | 10.1177/1747493018798527 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6582: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.